Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) View the PDF document
Table of Contents
View the documentAuthors
View the documentCountry Research Team Leaders
View the documentLaboratory Support
View the documentAcknowledgements
View the documentAcronyms
View the documentExecutive summary
View the document1. Background
Open this folder and view contents2. Methodology
View the document3. Results
Open this folder and view contents4. Discussion
Open this folder and view contents5. Conclusions and recommendations
View the documentReferences
Open this folder and view contentsTables
Open this folder and view contentsAnnexes
View the documentOther documents in the EDM Research Series
View the documentEDM Research Series No. 30
 

EDM Research Series No. 30

The Department of Essential Drugs and Medicines Policy (EDM) of the World Health Organization works to ensure that all people ⊥ wherever they may be ⊥ are able to obtain the drugs they need at a price that they and their country can afford, that these medicines are safe

Ensuring access to and rational use of medicines for all people is a difficult goal in itself, especially given today’s rapidly changing macroeconomic and national environments. Countries are experiencing the impacts of structural adjustment policies, globalization of world markets and new disease patterns. Widespread health system reforms with shifting priorities, and the changing relationship between the public and private sectors, further complicate this picture. Additionally, many governments lack crucial information to guide their national medicines policies in response to these challenges.

But operational research is making a vital contribution to identifying global and national drug sector problems and priority areas for intervention. At global level, the systematic development and analysis of internationally comparable data on pharmaceutical systems is enabling countries to learn from each other's experience and to strengthen their national drug policies. At the same time, national research is helping countries to analyse and overcome the constraints they face in developing and implementing these policies.

This document is just one in a series of research guidelines and studies that are helping to reduce the burden of disease and provide access to responsive health care for all.

Department of Essential Drugs and Medicines Policy, World Health Organization, 1211 Geneva 27, Switzerland

to previous section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018